{"name":"ValiRx Plc","slug":"valirx-plc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQanNaZlh6ODNtVkR1VDJSbFhNcHA5WVRrMlNGc3pPYTRDRWk0RlZRbDM3M25xa2FoR3BYSkJ6S0xjUWJwNFc2WHZyaFBrbUF6OFdFWUxldUxWczdEWUJvQlNvWVZpaUtEZDVfQmQ5M0FWTHBNLXdwNmk0b2R2cVllTUZoQkVTNnhVMmRMUHM5cF9nM0NPRFFQTXJLNGFaMXB3TmF3TEF3VEt1TEJBaWlnUGJhQXZ6VVNJMzlqTHMzbF9GeXpGazYyajU1VXI4cE9vdzktU1Rxd0o?oc=5","date":"2026-03-24","type":"trial","source":"TipRanks","summary":"ValiRx gains oncology spotlight with digital twin data and expanding scientific footprint - TipRanks","headline":"ValiRx gains oncology spotlight with digital twin data and expanding scientific footprint","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQOFpJV2ZQZzRZRjlCMGx1MGFvQlZnS1RqWDJ4a0lHRllZTlo0N192THBfeWUtbEQ2M1FMZGlFWE5OalQ1NGphdGdsbVVOZjRzMy1PZ1lnX0xGZ3d3cFZCTU9qLWI4dWxNejNKYWlKaVBUbWVJczFuaHp5YlhaYU83ME9yTkluREhEUmR4X1ctSzE3RWtmQU9GNQ?oc=5","date":"2026-01-09","type":"pipeline","source":"Share Talk","summary":"ValiRx plc (AIM: VAL) New Evaluation and Material Transfer Agreement - Share Talk","headline":"ValiRx plc (AIM: VAL) New Evaluation and Material Transfer Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQNzVQMnBDUlFEY3ROc09zQU12OEVUYkNlMjRLSXZwUmpldEhvZmo4VmwtS3B2N3lOek5KSXFHenpPS2ZUc3pVbWdxNzdXWm5lSzR5NExrb3pYc3FzbXIzTjBLTGFaU0hqTnFkenVtOHJvTzgtLVh0RjdCaGlkdGkwVS1KZGxCdw?oc=5","date":"2025-06-20","type":"pipeline","source":"Share Talk","summary":"ValiRx Plc (AIM: VAL): Ambrose Extends Option on VAL401 - Share Talk","headline":"ValiRx Plc (AIM: VAL): Ambrose Extends Option on VAL401","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPYUkxbHI2NEVwdGJDUG9iQkQ2b3IyLVVlZm84VXg5YXNDZEF1bUFmV2Z6QTdhaVYtck96eW9IQ29abXBuM0ZpWFg1Q3ljanZKdU51WmtyT0FValJRdXptc0ZCMUVnYUZ2VnBYVzJqZW1BRW81MmhFSk5nNXVNT2d3dkdIejYxZXVGbXh1czA4UzA2Q0dkMzlUemJJczZlRFU4YmlkdV9zTVZlSHp0VmRvWXBfay1tNGtVbGdVSG8wNlNWMUdnenNDNGU3WTlTdWxqZVdSY2VRNEk3OGJWeHp0OTdiYVVKd1REQ3Y5VjFZV1lyQi0wdGZYbGc5R1RMdw?oc=5","date":"2025-01-10","type":"pipeline","source":"Proactive Investors","summary":"ValiRx Advances Women's Health and Oncology Pipeline with Focus on Triple-Negative Breast Cancer - Proactive Investors","headline":"ValiRx Advances Women's Health and Oncology Pipeline with Focus on Triple-Negative Breast Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxNdG1RTFBNdWZIb2JyRE5xT0IxSkY0QUQyc2hEMXc4N3ROaFFycWNDenRycmgyMEs1Ym9MNTZvRXlXSkZIMjQ5blhubTduQV9weHV5V2R5U0tfbE5yV29ET1VWbDYyQ3J5azdfdmstOGpxZU9uR1VhUGRUWGh5amNqbjBPNHVWb3I4UEctdFljQ1lpQngxRFpHbDZwVGJPaGhYUnRVRHNyN192a1VmRHBSOWhHQ1gyRFdERTFOd2FYNEMtWkNyWEtEWG11T01POUtSeDk4T2JaaVdGc0drVHdoTzBWUk1xY09CVEdidVFrNVN4S1RCWlB5dlZla3N0YndJVF9USU9SVDJXWHphcXZVSUdnQVBQYzZjT3Jabg?oc=5","date":"2023-03-01","type":"pipeline","source":"proactiveinvestors.com","summary":"ValiRx shares jump on incorporation of new subsidiary which will be the cornerstone of its Contract Research Organisation - proactiveinvestors.com","headline":"ValiRx shares jump on incorporation of new subsidiary which will be the cornerstone of its Contract Research Organisatio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9nX2RmOEZaRHZfZ0hEblBRQm1ad0cxTmRQbE5wWUNoT3JKLWo2b0pZUHlYR1ROaVpsbVljNTY5emFaVW9LZ19iN2dib193c3NieXQ0?oc=5","date":"2019-09-26","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Nuformix plc (NFX.L) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Nuformix plc (NFX.L) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOVmo3SUhaLWJzZ292YWlGOXQxd1gxSWFpelRVeVBCdFBObnhDbnVfbjlFOGVWVDJiTUdzdTRFWEpTUXdva1VvMXdmdDAtdEMwWTh4dXVzWEVzRUs3RThKbDNqcm9kVkYtTzh4UkhFUmFMdy1Ia2x3NGw0LVdteVpoWG9yaUppNGVHMmdYSnhSU1kzM0NtRTI4M1JBRDhPeGE1YkowRllmbEdNc0VySXZvUUpqZ3hDRWMxRkE?oc=5","date":"2019-07-04","type":"trial","source":"proactiveinvestors.com","summary":"ValiRx readying itself for VAL301 clinical trials - proactiveinvestors.com","headline":"ValiRx readying itself for VAL301 clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPXzM1MjRIQlRGZmduYkdiYnVUZEpXdHlmQWZCU001WWl1MDFzUGFqUXBSS1NTVFQxcmg2MGdxVFYxNHVkTFRwUXowNkQ2U0RLblpTSkJ1NEZyNE0tbHdGRzdSSUx2akx5ckdMcDJSM0NtRzdjWVJ2M2hSS25FQ085czhMdDltVFNSZkpGMS1mdUZiY0FDQ3FXMGFRQS1CZFpOTHpZTnZuQUV2X25wYkpkMk0zNFA4azA?oc=5","date":"2019-06-26","type":"patent","source":"proactiveinvestors.com","summary":"ValiRx secures US patent for VAL201 cancer drug - proactiveinvestors.com","headline":"ValiRx secures US patent for VAL201 cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE5LaXR0RXB5SU85RHhMNGhHYTBvak8xdFAwVk9TYzdGT0s1WmJqQ2FLU2dzX094N3lzZHJxVmlHcWdTTDN6ck1TdHA4Yk5UajE2ZVpmbzBQdw?oc=5","date":"2017-07-31","type":"pipeline","source":"TradingView","summary":"VAL Stock Price and Chart — LSE:VAL - TradingView","headline":"VAL Stock Price and Chart — LSE:VAL","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}